Conditions: Rosacea
Keywords: Rosacea
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 449
Healthy volunteers: no

Brief summary:
A long-term, open-label, non-comparative safety and efficacy study of CD07805/47 gel 0.5% once daily in subjects with moderate to severe facial erythema associated with rosacea.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: CD07805/47 gel 0.5%
Intervention descriptions: intervention 1: In this open-label study, all subjects will receive treatment with CD07805/47 gel 0.5% applied once daily, for up to 12 months.

Protocol document: